The Boston.com Newsletter offers subscribers the latest news and breaking updates from the newsroom straight to their inbox, keeping them informed about everything happening in Boston. With a focus on staying up to date with current events, readers can rely on this newsletter to provide accurate and detailed information about key names and events in the Boston area. Say informed and connected with Boston.com’s Newsletter Signup.
Full Article
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The US FDA approved Vertex Pharmaceuticals' Journavx, a new pain pill designed to reduce addiction and overdose risks associated with opioids, offering an alternative for short-term pain relief post-surgery or injuries. The drug, priced at $15.50 per pill, works by blocking pain-signaling proteins rather than targeting brain receptors like opioids, showing promise despite modest effectiveness and some side effects. While Vertex faces challenges with its chronic pain drug pipeline, they plan to proceed with further...
Read more